Midday Update: HSI Ends at 26,851, Down 71 Points; HSTI at 5,815, Down 12 Points; ALI HEALTH Falls Over 5%; SHK PPT, CKH HOLDINGS, CLP HOLDINGS, BOC HONG KONG, and CONANT OPTICAL Reach New Highs

The analyst rating from the UBS research report is a "Buy" recommendation for CKH Holdings, driven by optimism about the company's potential to unlock value through asset sales, particularly in light of discussions to sell its Irish telecom operator, Three Ireland. The report highlights that the sale could enhance market expectations for CKH's engagement in mergers and acquisitions (M&A) in other operational markets. The target price set by the broker is HKD67, reflecting confidence in the company's strategic moves.

The analyst rating from Morgan Stanley for CKH HOLDINGS (00001.HK) is based on several key factors: 1. Positive Growth Expectations: Morgan Stanley anticipates positive growth in both Earnings Per Share (EPS) and Dividends Per Share (DPS) for CKH, particularly with the upcoming announcement of its 2025 results in March. 2. Corporate Actions: The broker expects that certain corporate actions will add value to the stock price and help narrow the discount to Net Asset Value (NAV). 3. High Probability of Success: Morgan Stanley estimates the probability of these positive outcomes occurring to be over 80%, which they describe as "highly likely." These factors collectively led to the assignment of an Overweight rating and a target price of HKD61 for the stock.